Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Prime Medicine (PRME) over the last 3 years, with Q3 2025 value amounting to $1.1 million.

  • Prime Medicine's Interest & Investment Income rose 6370.16% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 8602.02%. This contributed to the annual value of $3.5 million for FY2024, which is 2529.35% up from last year.
  • Prime Medicine's Interest & Investment Income amounted to $1.1 million in Q3 2025, which was up 6370.16% from $743000.0 recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Interest & Investment Income registered a high of $1.5 million during Q4 2024, and its lowest value of $410000.0 during Q3 2023.
  • Its 3-year average for Interest & Investment Income is $812400.0, with a median of $686500.0 in 2024.
  • Examining YoY changes over the last 5 years, Prime Medicine's Interest & Investment Income showed a top increase of 21323.83% in 2024 and a maximum decrease of 377.95% in 2024.
  • Over the past 3 years, Prime Medicine's Interest & Investment Income (Quarter) stood at $491000.0 in 2023, then surged by 213.24% to $1.5 million in 2024, then decreased by 25.81% to $1.1 million in 2025.
  • Its Interest & Investment Income was $1.1 million in Q3 2025, compared to $743000.0 in Q2 2025 and $1.2 million in Q1 2025.